The Case for Integrated RWE Generation Across the Product Lifecycle | October 22, 2025

We're thrilled to invite you to a webinar we are co-hosting with ISPOR on October 22, 2025, at 11 AM ET: "The Case for Integrated RWE Generation Across the Product Lifecycle." This session will explore how a unified approach to integrated RWE generation provides a clear view of a product’s clinical and commercial performance, from early development through post-market surveillance – and how to connect an end-to-end RWE strategy to business value.

•  Hear a use case directly from a top pharmaceutical organization in leveraging RWD on clinical development with a clear return on investment.
• Learn how to effectively communicate the value of RWD/E investments to key stakeholders.
• Unlock the growing role for trial tokenization and linkage to RWD to fully realize end-to-end evidence generation for clinical development and commercialization needs

Presenters:

• Ulka Campbell, PHD, SVP, Head of Scientific Strategy, Aetion, a Datavant Company (Moderator)
• Brian Bradbury, DSc, VP, Center for Observational Research, Amgen
• Arnaub Chatterjee, President and GM of Life Sciences, Datavant
• Nicolle Gatto, PhD, MPH, Chief Science Officer, Aetion, a Datavant Company